Design Therapeutics
Olivia B. has over 17 years of experience in the accounting field. Olivia began their career in 2004 as an Accounts Payable Supervisor for Henry Schein Orthodontics, Ortho Organizers Inc. In 2012, they became an Accounting Specialist at Carl Zeiss Vision. Olivia then moved to Kontron in 2013, where they worked as a Senior Staff Accountant for 6 years. In 2019, they joined Paladin Technologies as a Staff Accountant, and in 2021, they began working as an Accountant at Design Therapeutics.
Olivia B. holds a Bachelor of Business Administration (B.B.A.) from St. Paul University, where they studied Accounting and Business/Management.
This person is not in any offices
Design Therapeutics
1 followers
Design Therapeutics is pioneering novel small-molecule therapeutic candidates, called gene targeted chimeras (GeneTACs™), designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.